AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

71.078

-0.551-0.77%

Number of Gainers:1

Number of Losers:4

Number of Flat:12

PE:- -

High:71.690

Open:71.690

Low:70.484

Close:71.629

Volume:37.66M

Turnover:391.69K

Market Cap:653.76M

Float Cap:265.50M

Loading ...

Emyria Posts FY Net Loss Attributable A$6.1 Million

Emyria - FY Net Loss Attributable A$6.1 Mln

THOMSON REUTERS

Emyria - no Dividends Paid, Recommended or Declared During Fy2026

THOMSON REUTERS

Emyria - FY Revenue from Customer Sales and Clinical Services A$4.1 Mln

THOMSON REUTERS

Elixinol Wellness - no Dividends Paid, Recommended or Declared for H1 FY26

THOMSON REUTERS

Elixinol Wellness - There were no Dividends Paid, Recommended or Declared During the Current Financial Period

THOMSON REUTERS

Elixinol Wellness - H1 FY26 Loss After Tax A$1.07 Mln

THOMSON REUTERS

Elixinol Wellness - Completion Subject to Due Diligence, no Material Adverse Change, and Loan Note Holder Consents

THOMSON REUTERS

Elixinol Wellness - Deal Headline Consideration is A$465,000 Including Upfront, Deferred, Contingent and Earn-Out Payments

THOMSON REUTERS

Elixinol Wellness - Completion Expected in Early September 2026 Subject to Conditions

THOMSON REUTERS

Elixinol Wellness Ltd - Receives Binding Offer for US Divestment

THOMSON REUTERS

Cann Group Ltd-Preliminary Final Report

THOMSON REUTERS

Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026

THOMSON REUTERS

Analysts Have Made A Financial Statement On Botanix Pharmaceuticals Limited's (ASX:BOT) Yearly Report

Simply Wall St.

ECS Botanics Holdings Ltd - FY Net Loss Attributable A$1.9 Mln

THOMSON REUTERS

ECS Botanics Holdings Ltd - no Dividend Has Been Proposed or Declared

THOMSON REUTERS

ECS Botanics Holdings Ltd - FY Revenue from Ordinary Activities A$21.4 Mln

THOMSON REUTERS

Botanix Pharmaceuticals Ltd - no Dividend was Declared or Paid During Year

THOMSON REUTERS

Botanix Pharmaceuticals Ltd - FY Net Loss Attributable A$69.8 Mln

THOMSON REUTERS

Atlas Pearls Ltd - FY Total Revenue A$25.8 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK7502/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7502","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7502\",,,,,undefined,":{"symbol":"BK7502","market":"AU","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":71.07757,"timestamp":1788155725268,"preClose":71.62893,"halted":0,"volume":37657762,"delay":0,"changeRate":-0.007697,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-0.551361,"latestTime":"08-31 16:00:00 AEST","open":71.69046,"high":71.69046,"low":70.48373,"amount":391692,"amplitude":0.016847,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788134400000,1788156000000]],"turnoverRate":0.004243,"increases":1,"decrements":3,"flats":14,"marketCap":653759837.75,"floatMarketCap":265497621.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7502\",,,,,undefined,":{"symbol":"BK7502","high":71.69046,"amplitude":0.016847,"preClose":71.62893,"low":70.48373,"latestPrice":71.07757,"volume":37657762,"delay":0,"open":71.69046,"prevYearClose":137.30031,"prevWeekClose":71.629,"prevMonthClose":70.903,"prevQuarterClose":68.077,"fiveDayClose":70.25,"twentyDayClose":72.029,"sixtyDayClose":72.461,"secType":"PLATE","market":"AU","turnoverRate":0.004243,"marketCap":653759837.75,"floatMarketCap":265497621.375,"timestamp":1788155725268,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7502\",,,,undefined,":{"bkCode":"BK7502","up":1,"down":4,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7502\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663074943","title":"Emyria Posts FY Net Loss Attributable A$6.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074943","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074943?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:23","pubTimestamp":1788171795,"startTime":"0","endTime":"0","summary":"BRIEF-Emyria Posts FY Net Loss Attributable A$6.1 MillionAug 31 (Reuters)-Emyria LtdEMD.AX:FY NET LOSS ATTRIBUTABLE A$6.1 MILLIONFY REVENUE FROM CUSTOMER SALES AND CLINICAL SERVICES A$4.1 MILLIONNO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING FY2026Further company coverage:EMD.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMD.AU","BK7113","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663758030","title":"Emyria - FY Net Loss Attributable A$6.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663758030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663758030?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:39","pubTimestamp":1788165563,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","EMD.AU","BK7113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663755580","title":"Emyria - no Dividends Paid, Recommended or Declared During Fy2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663755580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663755580?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:39","pubTimestamp":1788165563,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","BK7113","EMD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663755540","title":"Emyria - FY Revenue from Customer Sales and Clinical Services A$4.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663755540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663755540?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:39","pubTimestamp":1788165563,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","EMD.AU","BK7096","BK7113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663502215","title":"Elixinol Wellness - no Dividends Paid, Recommended or Declared for H1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2663502215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663502215?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:57","pubTimestamp":1788155878,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R06J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BK7502","EXL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663153022","title":"Elixinol Wellness - There were no Dividends Paid, Recommended or Declared During the Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663153022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663153022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:57","pubTimestamp":1788155878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R06J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7111","EXL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663137022","title":"Elixinol Wellness - H1 FY26 Loss After Tax A$1.07 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663137022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663137022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:57","pubTimestamp":1788155878,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R06J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","EXL.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663802237","title":"Elixinol Wellness - Completion Subject to Due Diligence, no Material Adverse Change, and Loan Note Holder Consents","url":"https://stock-news.laohu8.com/highlight/detail?id=2663802237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663802237?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","EXL.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663371022","title":"Elixinol Wellness - Deal Headline Consideration is A$465,000 Including Upfront, Deferred, Contingent and Earn-Out Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2663371022","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663371022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXL.AU","BK7111","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022327","title":"Elixinol Wellness - Completion Expected in Early September 2026 Subject to Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022327?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","EXL.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022320","title":"Elixinol Wellness Ltd - Receives Binding Offer for US Divestment","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022320?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","EXL.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021480","title":"Cann Group Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021480?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","CAN.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002145","title":"Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002145?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAN.AU","BK7096","BK7508","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663601992","title":"Analysts Have Made A Financial Statement On Botanix Pharmaceuticals Limited's (ASX:BOT) Yearly Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663601992","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663601992?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:17","pubTimestamp":1787951858,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Limited ( ASX:BOT ) just released its latest yearly report and things are not looking great. It...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/analysts-have-made-a-financial-statement-on-botanix-pharmace","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/analysts-have-made-a-financial-statement-on-botanix-pharmace","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","BOT","BK7502","BOT.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662610039","title":"ECS Botanics Holdings Ltd - FY Net Loss Attributable A$1.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662610039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662610039?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:33","pubTimestamp":1787869999,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ECS.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039643","title":"ECS Botanics Holdings Ltd - no Dividend Has Been Proposed or Declared","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039643?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:33","pubTimestamp":1787869999,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7502","ECS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039617","title":"ECS Botanics Holdings Ltd - FY Revenue from Ordinary Activities A$21.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039617?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:33","pubTimestamp":1787869999,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ECS.AU","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662879531","title":"Botanix Pharmaceuticals Ltd - no Dividend was Declared or Paid During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2662879531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662879531?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:54","pubTimestamp":1787730880,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0GV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BOT.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795315","title":"Botanix Pharmaceuticals Ltd - FY Net Loss Attributable A$69.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795315","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795315?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:54","pubTimestamp":1787730880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","BK7508","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662768094","title":"Atlas Pearls Ltd - FY Total Revenue A$25.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662768094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662768094?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:48","pubTimestamp":1787701715,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7131","BK7502","ATP.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}